Table 3. The levels of cytokines in different disease stages.
| Cytokine | PACG-E (n = 17) | PACG-A (n = 11) | PACG-L (n = 12) | P value* |
|---|---|---|---|---|
| G-CSF | 0.9 (1.3) | 2.8 (21.7) | 0.8 (2.4) | 0.017 |
| IL-6 | 1.5 (1.9) | 3.6 (13.9) | 1.7 (8.7) | 0.159 |
| IL-8 | 4.4 (3.8) | 8.8 (13.5) | 8.2 (5.7) | 0.107 |
| MCP-1 | 748.0 (365.0) | 964.0 (685.0) | 1068.5 (906.8) | 0.026 |
| MCP-3 | 3.2 (2.1) | 3.2 (2.1) | 3.2 (1.9) | 0.957 |
| MDC | 36.4 (35.1) | 25.7 (25.4) | 34.5 (24.8) | 0.725 |
| MIP-1β | 7.0 (8.3) | 9.4 (9.5) | 2.9 (5.8) | 0.196 |
| VEGF | 99.3 (121.1) | 104.0 (90.1) | 126.5 (123.8) | 0.459 |
Abbreviations: PACG-E, PACG in early stage; PACG-A, PACG in advanced stage; PACG-L, PACG in late stage.
Data are expressed as the median (interquartile range), pg/ml.
*
Kruskal–Wallis test was performed to compare the three groups.